SMSMED Cash Flow Statement

Financials in millions DKK. Fiscal year is October - September.

Millions DKK. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	5.37	12.22	11.37	8.16	4.51
Depreciation & Amortization	6.16	4.46	0.61	0.02	0.02
Other Operating Activities	-5.36	1.34	3.18	0.21	1.31
Change in Other Net Operating Assets	-18.1	-26.38	-25.73	-4.37	3.53
Operating Cash Flow	-11.93	-8.37	-10.57	4.02	9.38
Operating Cash Flow Growth	-	-	-	-57.10%	-
Capital Expenditures	-19.25	-40.82	-13.76	-	-
Sale of Property, Plant & Equipment	4.45	1.24	-	-	-
Investment in Securities	-0.02	-0.29	-0.01	-0.27	-0.03
Investing Cash Flow	-14.82	-39.87	-13.77	-0.27	-0.03
Long-Term Debt Issued	-	22.73	-	-	-
Long-Term Debt Repaid	-	-1.59	-	-	-
Net Debt Issued (Repaid)	9.76	21.14	-	-	-
Issuance of Common Stock	0.24	0.07	30	19.46	-
Repurchase of Common Stock	-	-	-	-	-2.77
Other Financing Activities	-0	-0.03	-3.3	-3.87	-
Financing Cash Flow	10	21.19	26.7	11.07	-2.77
Foreign Exchange Rate Adjustments	-0.2	-0.26	-	-	-
Net Cash Flow	-16.95	-27.3	2.36	14.83	6.58
Free Cash Flow	-31.18	-49.19	-24.33	4.02	9.38
Free Cash Flow Growth	-	-	-	-57.10%	-
Free Cash Flow Margin	-15.79%	-25.73%	-22.01%	5.62%	22.36%
Free Cash Flow Per Share	-1.14	-1.80	-0.91	-	-
Cash Interest Paid	1.83	0.72	0.25	0.54	0.28
Cash Income Tax Paid	6.98	2.49	0.17	2.17	-0.01
Levered Free Cash Flow	-29.43	-48.17	-30.36	2.33	-
Unlevered Free Cash Flow	-28.37	-47.56	-30.2	2.66	-
Change in Net Working Capital	20.62	21.59	26.27	4.16	-

Source: S&P Capital IQ. Standard template. Financial Sources.